Openspace Ventures led a USD10m pre-Series A for Broom, an Indonesia-based auto financing platform, with participation from Quona Capital, MUFG Innovation Partners, BRI Ventures and AC Ventures. Read More
Viewpoint Software, a Malaysia-based business entity engagement software provider, raised USD40m from BPEA EQT and CPP Investments. … Read More
INCE Capital and Qiming Venture Partners led a USD50m Series B for Allorion Therapeutics, a China-based drug developer that focuses on treating oncology and autoimmune diseases, with participation from TF Capital, Long River Investment, 3SBio, Octagon Capital and Elikon Venture. Read More
Premji Invest led a USD110m Series D for Mintifi, an India-based supply chain financing platform, with follow-on from International Finance Corporation (IFC), Norwest Venture Partners, Elevation Capital and others. Read More
Accion Venture Lab and Sturgeon Capital led a USD6.4m seed round for Trukkr, a Pakistan-based trucking logistics platform, with participation from Peter Findley (Anchorless Bangladesh), Haitou Global and Al Zayani Venture Capital. … Read More
CPP Investments acquired an additional 14% stake in India-based independent power producer ReNew Energy Global from Goldman Sachs for USD268m, to become the majority shareholder. … Read More
Both long-term structural trends and recent shifts in market dynamics are driving the growth of private credit activity in Asia, which reached record levels in 2022. This report explores recent trends in activity in the region and outlines key themes for 2023 and beyond, as reported to GPCA by investors… Read More
As digitization spreads across industries and with the continued growth of venture capital, tech investment has grown to represent the majority of private capital activity in Asia, even amidst the global correction in 2022. This report examines some of the contours of the changing tech investment landscape in China, India… Read More
Kotak Mahindra Advisors, the alternative assets arm of Kotak Mahindra Group, invested INR10.7bn (~USD129.4m) in Biocon, an India-based pharmaceuticals manufacturer. Read More
Private capital investment activity across GPCA’s markets remained strong by historical standards in 2022, with fund managers deploying USD208b. Overall deal value declined 22% from 2021, yet 2022 was still the second-highest on record. The drop-off over the course of 2022 was concentrated in late-stage VC and growth PE rounds,… Read More
(default archive template)